Phase 1 study of CTX-471, a novel CD137 agonist antibody, in patients with progressive disease following PD-1/PD-L1 inhibitors in metastatic or locally advanced malignancies. This is an ASCO Meeting ...
Leveraging innate immunity with AFM24, a novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager: Interim results for the non-small cell lung cancer (NSCLC) cohort.
The National Electrical Manufacturers Association (NEMA) has published ANSI/NEMA CC 1-2009 Electric Power Connection for Substations. The standard was produced by NEMA's Electrical Connector Section, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results